Short Interest in The Oncology Institute, Inc. (NASDAQ:TOIIW) Declines By 22.9%

The Oncology Institute, Inc. (NASDAQ:TOIIW) was the recipient of a large decline in short interest during the month of September. As of September 15th, there was short interest totalling 2,700 shares, a decline of 22.9% from the August 31st total of 3,500 shares. Based on an average daily trading volume, of 9,600 shares, the short-interest ratio is presently 0.3 days.

Oncology Institute Stock Performance

TOIIW stock remained flat at $0.02 during midday trading on Friday. The company’s stock had a trading volume of 5,976 shares, compared to its average volume of 21,618. The company’s 50-day moving average is $0.02 and its 200-day moving average is $0.08. Oncology Institute has a twelve month low of $0.01 and a twelve month high of $0.37.

Oncology Institute Company Profile

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.